BBLGBone Biologics Corporation

$2M

FY 2013 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$672,000

Net Income

-$1M

EPS (Diluted)

$-37.48

Cash Flow

Operating Cash Flow

-$525,365

Free Cash Flow

-$525,365

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$87,305

Total Liabilities

$6M

Stockholders' Equity

-$6M

Cash & Equivalents

$1,538

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$672,000	-$5,231	-12746.5%
Net Income	-$1M	-$715	-151228.7%

BBLG FY 2013 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena